West African pharmaceutical sovereignty taking shape in Lomé
Lomé, August 12, 2026 — The future of West Africa’s healthcare hangs in the balance between reliance on imported medications and the urgent need for local pharmaceutical production. This critical juncture brought together medical and academic leaders from across the subregion at the Agora Senghor in Lomé, where a decisive shift in regional health strategy was set in motion.
The 21st edition of the Federation of West African Pharmacy Students (FESPAO) Scientific and Cultural Conference served as more than a platform for dialogue—it became the launchpad for a new era in medical innovation. The emerging generation of pharmacists is no longer content with administrative roles; they are demanding a radical transformation. The focus is shifting from mere drug distribution to full-scale industrialization, genomic research, and scientifically validating traditional knowledge.
Local production as a national security imperative
The global pandemic and recent supply chain disruptions exposed a stark reality: Africa’s heavy dependence on imported pharmaceuticals is not just an economic concern—it’s a national security vulnerability. This was the core message delivered during the summit.
Professor Gado Tchangbédji, Togo’s Minister Delegate for Higher Education and Research, outlined the government’s bold vision under President Faure Essozimna Gnassingbé’s leadership: transforming innovation and local pharmaceutical production into the subregion’s strongest defense against future health crises. The state is committing substantial resources to strengthen scientific cooperation and applied research initiatives.
The genomic epidemiology and indigenous knowledge bet
True pharmaceutical sovereignty, however, cannot be achieved by simply replicating foreign formulas. The path forward requires tailoring treatments to Africa’s unique genetic and epidemiological landscape. By prioritizing “genomic epidemiology,” the Lomé conference highlighted an urgent scientific need: developing therapies specifically adapted to the genetic makeup of African populations—groups that have been historically underrepresented in global clinical trials.
This forward-thinking scientific approach is paired with a conscious revival of indigenous wisdom. Experts are advocating for the industrial-scale development of traditional pharmacopeia. No longer should herbal medicine remain confined to informal use. Instead, it must undergo rigorous clinical testing to identify and patent entirely new, 100% African-derived active compounds.
Redefining the pharmacist’s role
Yet, even the most ambitious plans face a critical human capital challenge. As the industry evolves, so too must the training of healthcare professionals. Professor Tchin Darré, Togo’s Minister Delegate for Health and Dean of the Faculty of Health Sciences at the University of Lomé, emphasized that reforming academic curricula is the cornerstone of this revolution. The pharmacist of tomorrow in West Africa cannot be confined to dispensing medication behind a counter. They must emerge as a research leader, a key player in manufacturing, and an expert in validating indigenous knowledge systems.
As discussions in Lomé progress, the goal of these 21st FESPAO Assises is clear: convert these academic debates into enforceable public policies. The aim is to ensure that universal healthcare access in West Africa no longer depends on factories located thousands of miles away from patients.
The stakes could not be higher. Without a robust local pharmaceutical industry and research efforts rooted in African realities, West Africa will remain beholden to solutions designed elsewhere. In the face of future pandemics, this dependence could have deadly consequences. True health sovereignty will be measured by the region’s ability to turn these resolutions into tangible action—ensuring every African patient receives care designed, validated, and produced on their own continent.
